Pinnacle Wealth Planning Services, Inc. Sangamo Therapeutics, Inc Transaction History

Pinnacle Wealth Planning Services, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$2.77 - $5.07 $26,902 - $49,239	-9,712 Reduced 40.3%	14,386 $45,000
Q3 2022 Nov 09, 2022	BUY	$4.27 - $6.39 $28,109 - $42,065	6,583 Added 37.58%	24,098 $118,000
Q2 2022 Aug 03, 2022	BUY	$3.28 - $6.21 $1,131 - $2,142	345 Added 2.01%	17,515 $73,000
Q1 2022 Apr 20, 2022	BUY	$5.23 - $7.82 $89,799 - $134,269	17,170 New	17,170 $100,000
Q1 2021 Apr 29, 2021	SELL	$10.88 - $17.05 $56,227 - $88,114	-5,168 Closed	0 $0

Q4 2020 Feb 12, 2021	BUY	$9.23 - $18.18 $47,700 - $93,954	5,168 New	5,168 $80,000

138

100M

35.5K

65.8K

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $50.1M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Pinnacle Wealth Planning Services, Inc., based on Form 13F filings with the SEC.

Stay updated on Pinnacle Wealth Planning Services, Inc. with notifications on news.